Urology and Renal conditions Flashcards
Renal and uro conditions:
- Acute kidney injury (AKI)
- Amyloidosis
- Benign prostatic hyperplasia
- Bladder cancer
- Chronic kidney disease (CKD)
- Epididymitis and orchiditis
- Glomerulonephritis
- Hydrocoele
- Nephrotic syndrome
- Polycystic kidney disease
- Prostate cancer
- Renal artery stenosis
- Renal cell carcinoma
- Testicular cancer
- Testicular torsion
- Urinary tract calculi
- Urinary tract infection
- Varicocoele
Acute kidney injury:
Define
-
An abrupt loss of kidney function resulting in the retention of urea and other nitrogenous waste products and the dysregulation of extracellular volume and electrolytes.
- NOTE: this can occur in patients with previously normal kidneys or in patients with pre-existing renal disease
Acute kidney injury:
Define
-
An abrupt loss of kidney function resulting in the retention of urea and other nitrogenous waste products and the dysregulation of extracellular volume and electrolytes.
- NOTE: this can occur in patients with previously normal kidneys or in patients with pre-existing renal disease
AKI Classification:
-
KDIGO Classification of AKI
- Increase in serum creatinine > 26 mmol/L within 48 hrs
- Increase in serum creatinine to > 1.5 times baseline within the preceding 7 days
- Urine volume < 0.5 ml/kg/hr for 6 hours
Explain the aetiology/risk factors of AKI:
-
Pre-Renal (90%)
- Hypovolaemia (e.g. haemorrhage, severe vomiting)
- Heart failure
- Cirrhosis
- Nephrotic syndrome
- Hypotension (e.g. shock, sepsis, anaphylaxis)
- Renal hypoperfusion (e.g. NSAIDs, ACE inhibitors, ARBs, renal artery stenosis)
-
Intrinsic Renal
- Glomerular - glomerulonephritis, haemolytic uraemic syndrome
- Tubular - acute tubular necrosis
- Interstitial - acute interstitial nephritis (e.g. NSAIDs, autoimmune)
- Vasculitides (e.g. Wegener’s granulomatosis)
- Eclampsia
-
Post-Renal (due to obstruction)
- Calculi
- Urethral stricture
- Prostatic hypertrophy or malignancy
- Bladder tumour
-
RISK FACTORS
- Age
- Chronic kidney disease
- Comorbidities (e.g. heart failure)
- Sepsis
- Hypovolaemia
- Use of nephrotoxic medications
- Emergency surgery
- Diabetes mellitus
Summarise the epidemiology of AKI
- 15% of adults admitted to hospital will develop an AKI
- Most common in the ELDERLY
Recognise the presenting symptoms of AKI
- Depends on underlying CAUSE
- Oliguria/anuria
- NOTE: abrupt anuria suggests post-renal obstruction
- Nausea/vomiting
- Dehydration
- Confusion
Recognise the signs of AKI on physical examination
- Hypertension
- Distended bladder
- Dehydration - postural hypotension
- Fluid overload (in heart failure, cirrhosis, nephrotic syndrome) - raised JVP, pulmonary and peripheral oedema
- Pallor, rash, bruising (vascular disease)
Identify appropriate investigations for AKI
-
Urinalysis
- Blood - suggests nephritic cause
- Leucocyte esterase and nitrites - UTI
- Glucose
- Protein
- Urine osmolality
-
Bloods
- FBC
- Blood film
- U&Es
- Clotting
- CRP
-
Immunology
- Serum immunoglobulins and protein electrophoresis - for multiple myeloma
- Also check for Bence-Jones proteins in the urine
- ANA - associated with SLE
- Also check anti-dsDNA antibodies (high in active lupus)
- Complement levels - low in active lupus
- Anti-GBM antibodies - Goodpasture’s syndrome
- Antistreptolysin-O antibodies - high after Streptococcal infection
- Serum immunoglobulins and protein electrophoresis - for multiple myeloma
- Virology - check for hepatitis and HIV
-
Ultrasound
- Check for post-renal cause
- Look for hydronephrosis
-
Other Imaging
- CXR - pulmonary oedema
- AXR - renal stones
Generate a management plan for AKI
- Treat the cause
-
FOUR main components to management:
- Protect patient from hyperkalaemia (calcium gluconate)
- Optimise fluid balance
- Stop nephrotoxic drugs
- Consider for dialysis
- Monitor serum creatinine, sodium, potassium, calcium, phosphate and glucose
- Identify and treat infection
- Urgent relief of urinary tract obstruction
- Refer to nephrology if intrinsic renal disease is suspected
-
Renal Replacement Therapy (RRT) considered if:
- Hyperkalaemia refractory to medical management
- Pulmonary oedema refractory to medical management
- Severe metabolic acidaemia
- Uraemic complications
Identify possible complications of AKI
- Pulmonary oedema
- Acidaemia
- Uraemia
- Hyperkalaemia
- Bleeding
Summarise the prognosis for patients with AKI
Summarise the prognosis for patients with AKI
- Inpatient mortality varies depending on cause and comorbidities
- Indicators of poor prognosis:
- Age
- Multiple organ failure
- Oliguria
- Hypotension
- CKD
- Patients who develop AKI are at increased risk of developing CKD
Summarise the prognosis for patients with AKI
Summarise the prognosis for patients with AKI
- Inpatient mortality varies depending on cause and comorbidities
- Indicators of poor prognosis:
- Age
- Multiple organ failure
- Oliguria
- Hypotension
- CKD
- Patients who develop AKI are at increased risk of developing CKD
Identify possible complications of AKI
- Pulmonary oedema
- Acidaemia
- Uraemia
- Hyperkalaemia
- Bleeding
Generate a management plan for AKI
- Treat the cause
-
FOUR main components to management:
- Protect patient from hyperkalaemia (calcium gluconate)
- Optimise fluid balance
- Stop nephrotoxic drugs
- Consider for dialysis
- Monitor serum creatinine, sodium, potassium, calcium, phosphate and glucose
- Identify and treat infection
- Urgent relief of urinary tract obstruction
- Refer to nephrology if intrinsic renal disease is suspected
-
Renal Replacement Therapy (RRT) considered if:
- Hyperkalaemia refractory to medical management
- Pulmonary oedema refractory to medical management
- Severe metabolic acidaemia
- Uraemic complications
Identify appropriate investigations for AKI
-
Urinalysis
- Blood - suggests nephritic cause
- Leucocyte esterase and nitrites - UTI
- Glucose
- Protein
- Urine osmolality
-
Bloods
- FBC
- Blood film
- U&Es
- Clotting
- CRP
-
Immunology
- Serum immunoglobulins and protein electrophoresis - for multiple myeloma
- Also check for Bence-Jones proteins in the urine
- ANA - associated with SLE
- Also check anti-dsDNA antibodies (high in active lupus)
- Complement levels - low in active lupus
- Anti-GBM antibodies - Goodpasture’s syndrome
- Antistreptolysin-O antibodies - high after Streptococcal infection
- Serum immunoglobulins and protein electrophoresis - for multiple myeloma
- Virology - check for hepatitis and HIV
-
Ultrasound
- Check for post-renal cause
- Look for hydronephrosis
-
Other Imaging
- CXR - pulmonary oedema
- AXR - renal stones
Recognise the signs of AKI on physical examination
- Hypertension
- Distended bladder
- Dehydration - postural hypotension
- Fluid overload (in heart failure, cirrhosis, nephrotic syndrome) - raised JVP, pulmonary and peripheral oedema
- Pallor, rash, bruising (vascular disease)
Recognise the presenting symptoms of AKI
- Depends on underlying CAUSE
- Oliguria/anuria
- NOTE: abrupt anuria suggests post-renal obstruction
- Nausea/vomiting
- Dehydration
- Confusion
Summarise the epidemiology of AKI
- 15% of adults admitted to hospital will develop an AKI
- Most common in the ELDERLY
Explain the aetiology/risk factors of AKI:
-
Pre-Renal (90%)
- Hypovolaemia (e.g. haemorrhage, severe vomiting)
- Heart failure
- Cirrhosis
- Nephrotic syndrome
- Hypotension (e.g. shock, sepsis, anaphylaxis)
- Renal hypoperfusion (e.g. NSAIDs, ACE inhibitors, ARBs, renal artery stenosis)
-
Intrinsic Renal
- Glomerular - glomerulonephritis, haemolytic uraemic syndrome
- Tubular - acute tubular necrosis
- Interstitial - acute interstitial nephritis (e.g. NSAIDs, autoimmune)
- Vasculitides (e.g. Wegener’s granulomatosis)
- Eclampsia
-
Post-Renal (due to obstruction)
- Calculi
- Urethral stricture
- Prostatic hypertrophy or malignancy
- Bladder tumour
-
RISK FACTORS
- Age
- Chronic kidney disease
- Comorbidities (e.g. heart failure)
- Sepsis
- Hypovolaemia
- Use of nephrotoxic medications
- Emergency surgery
- Diabetes mellitus
AKI Classification:
-
KDIGO Classification of AKI
- Increase in serum creatinine > 26 mmol/L within 48 hrs
- Increase in serum creatinine to > 1.5 times baseline within the preceding 7 days
- Urine volume < 0.5 ml/kg/hr for 6 hours
Bladder Cancer
Define bladder cancer
-
Malignancy of bladder cells
- Most bladder cancers are transitional cell carcinomas
- RARELY, bladder cancers may be squamous cell carcinomas associated with chronic inflammation (e.g. schistosomiasis)
Explain the aetiology/risk factors of bladder cancer
- UNKNOWN
-
Risk Factors
- Smoking
- Dye stuffs (naphthylamines and benzidine)
- Cyclophosphamide treatment
- Pelvic irradiation
- Chronic UTIs
- Schistosomiasis
Summarise the epidemiology of bladder cancer
- 2% of cancers
- 2nd most common cancer of the genitourinary tract
- 2-3 x more common in MALES
- Peak incidence: 50-70 yrs
Recognise the presenting symptoms of bladder cancer
- Painless macroscopic haematuria
- Irritative/storage symptoms
- Frequency
- Urgency
- Nocturia
- Recurrent UTIs
- Rarely: ureteral obstruction
Recognise the signs of bladder cancer on physical examination
- Often NO SIGNS
- Bimanual examination may be performed as part of disease staging
Identify appropriate investigations for bladder cancer
- Cystoscopy - allows visualisation, biopsy or removal
- Ultrasound
- Intravenous urography
- CT/MRI for staging
Prostate Cancer
Define prostate cancer
- Primary malignant neoplasm of the prostate gland
Explain the aetiology/risk factors of pancreatic cancer
- UNKNOWN
-
Risk Factors
- Age
- Afro-Caribbean
- Family history
- Dietary factors
- Occupational exposure to cadmium
Summarise the epidemiology of prostate cancer
- COMMON
- 2nd most common cause of male cancer deaths
Recognise the presenting symptoms of prostate cancer
- Often ASYMPTOMATIC
-
Lower Urinary Tract Obstruction
- Frequency
- Hesitancy
- Poor stream
- Terminal dribbling
- Nocturia
-
Metastatic Spread
- Bone pain
- Cord compression
- Systemic symptoms: malaise, anorexia, weight loss
- Paraneoplastic syndromes (e.g. hypercalcaemia)
Recognise the signs of prostate cancer on physical examination
- Asymmetrical hard nodular prostate
- Loss of midline sulcus
Identify appropriate investigations for prostate cancer
-
Bloods
- FBC
- U&Es
- PSA
- NOTE: not a very specific test for prostate cancer
- Acid phosphatase
- LFTs
- Bone profile
-
CT/MRI Scan
- Assesses extent of local invasion and lymph node involvement
- Transrectal Ultrasound and Needle Biopsy
- Isotope Bone Scan - check for bone metastases
Renal Cell Cancer
Define renal cell cancer
- Primary malignancy of the kidneys
Explain the aetiology/risk factors of renal cell cancer
- Renal clear cell carcinoma (80%) - UNKNOWN CAUSE
- Papillary carcinoma (10%) - UNKNOWN CAUSE
- Transitional cell carcinoma (10%)
- NOTE: these occur at the renal pelvis
-
Risk Factors
- Associated with certain inherited conditions:
- von Hippel-Lindau disease
- Mutation in the von Hippel-Lindau protein, which causes headaches, balance issues, dizziness, limb weakness, vision problems and high blood pressure
- Tuberous sclerosis
- A rare genetic disease that causes benign tumours to grow in the brain and other organs (e.g. skin, kidneys, lungs, eyes)
- Polycystic kidney disease
- Familial renal cell cancer
- Smoking
- Chronic dialysis
- von Hippel-Lindau disease
- NOTE: renal cell cancer can cause abnormal LFTs in the absence of liver metastases = Strauffer’s Syndrome
- Associated with certain inherited conditions:
Summarise the epidemiology of renal cell cancer
- UNCOMMON
- 3% of all adult malignancies
- Peak incidence: 40-60 yrs
Recognise the signs of renal cell cancer on physical examination
- Palpable renal mass
- Hypertension
- Plethora
- Anaemia
- A left-sided tumour can obstruct the left testicular vein as it joins the left renal vein, and cause a left-sided varicocoele
Identify appropriate investigations for renal cell cancer
-
Urinalysis
- Haematuria
- Cytology
-
Bloods
- FBC
- U&Es
- Calcium
- LFTs
- High ESR (in 75%)
-
Abdominal Ultrasound
- Best first-line investigation
- Can distinguish between solid masses and cystic structures
-
CT/MRI
- Useful for staging
- Staging system: Robson Staging
- Useful for staging
Testicular Cancer
Define testicular cancer
- Malignant tumour of the testes
- Types:
- Seminomas - 50%
- Non-seminomatous germ-cell tumours and teratomas - 30%
- RARE: gonadal stromal tumours (Sertoli and Leydig cell tumours) and non-Hodgkin’s lymphoma
Recognise the presenting symptoms of renal cell cancer
-
Renal Cell Carcinoma
- Usually present LATE
- Asymptomatic in 90%
- Triad of Symptoms:
- Haematuria
- Flank pain
- Abdominal mass
-
Transitional Cell Carcinoma
- Presents EARLIER with haematuria
-
Systemic Signs of Malignancy
- Weight loss
- Malaise
- Paraneoplastic syndromes (e.g. fever, hypercalcaemia, polycythaemia)
Explain the aetiology/risk factors of testicular cancer
- UNKNOWN
-
Risk Factors
- Maldescended testes
- Ectopic testes
- Atrophic tests
Summarise the epidemiology of testicular cancer
- UNCOMMON
- 1% of male malignancies
- Common age of onset: 18-35 yrs
Recognise the presenting symptoms of testicular cancer
- Swelling or discomfort of the testes
- Backache due to para-aortic lymph node enlargement
- Lung metastases –> SOB, haemoptysis
Recognise the signs of testicular cancer on physical examination
- Painless, hard testicular mass
- There may be a secondary hydrocoele
- Lymphadenopathy (e.g. supraclavicular, para-aortic)
- Gynaecomastia (tumour produces hCG)
Identify appropriate investigations for testicular cancer
-
Bloods
- FBC
- U&Es
- LFTs
- Tumour Markers
- a-fetoprotein
- b-hCG
- LDH
- Urine Pregnancy Test - will be positive if the tumour produces b-hCG
- CXR - show lung metastases
-
Testicular Ultrasound
- Allows visualisation of the tumour
- Can see associated hydrocoele
-
CT Abdomen and Thorax - allows staging
- Staging System: Royal Marsden Hospital Staging
Benign Prostatic Hyperplasia
Define benign prostatic hyperplasia
- Slowly progressive nodular hyperplasia of the periurethral (transitional) zone of the prostate gland
- It is the most frequent cause of LUTS in adult males
Explain the aetiology/risk factors of benign prostatic hyperplasia
- UNKNOWN
- Link with hormonal changes (e.g. androgens)
- Risk Factors: reduced risk with soya/vegetable based diets and negative association with cirrhosis
Summaries the epidemiology of benign prostatic hyperplasia
- COMMON
- 70% of men > 70 yrs have histological BPH (50% of them will experience symptoms)
- More common in the west than the east
- More common in Afro-Caribbeans
Recognise the presenting symptoms of benign prostatic hyperplasia
-
Obstructive Symptoms
- Hesitancy
- Poor or intermittent stream
- Terminal dribbling
- Incomplete voiding
-
Irritative/Storage Symptoms
- Frequency
- Urgency
- Urge incontinence (leakage of urine that accompanies an intense desire to pass water with failure of restraint)
- Nocturia
-
TIP: the obstructive and irritative symptoms can be remembered using the mnemonic FUND HIPS
- Frequency
- Urgency
- Nocturia
- Dysuria
- Hesitancy
- Incomplete voiding
- Poor stream
- Smell/odour
-
Acute Retention Symptoms
- Sudden inability to pass urine
- Associated with SEVERE PAIN
-
Chronic Retention Symptoms
- Painless
- Frequency - with passage of small volumes of urine
- Nocturia is a major feature
Recognise the signs of benign prostatic hyperplasia on physical examination
- DRE - the prostate is usually smoothly enlarged with a palpable midline groove
- NOTE: there is poor correlation between the size and the severity of the symptoms
-
Signs of Acute Retention
- Suprapubic pain
- Distended, palpable bladder
-
Signs of Chronic Retention
- A large distended painless bladder (volume > 1 L)
- Signs of renal failure
Identify appropriate investigations for benign prostatic hyperplasia
-
Urinalysis
- Check for UTI signs and blood
-
Bloods
- U&Es - check for impaired renal function
- PSA
-
Midstream Urine
- MC&S
-
Imaging
- US of urinary tract (check for hydronephrosis)
- Bladder scanning to measure pre- and postvoiding volumes
- Transrectal Ultrasound Scan (TRUS) - allows assessment of bladder size and volume
- Flexible Cystoscopy
Generate a management plan for benign prostatic hyperplasia
-
In Emergency (acute urinary retention)
- Catheterisation
-
Conservative (if mild)
- Watchful waiting
-
Medical
- Selective a-blockers (e.g. tamsulosin) relax the smooth muscle of the internal urinary sphincter and prostate capsule
- 5a-reductase inhibitors (e.g. finasteride) will inhibit the conversion of testosterone to dihydrotestosterone, which can reduce prostate size by around 20%
-
Surgery
- TURP
- Open prostatectomy
Identify possible complications of benign prostatic hyperplasia
- Recurrent UTI
- Acute or chronic urinary retention
- Urinary stasis
- Bladder diverticula
- Stone development
- Obstructive renal failure
- Post-obstructive diuresis
-
Complications of TURP
- Retrograde ejaculation (you ejaculate up into your bladder because the internal urinary sphincter is relaxed)
- Haemorrhage
- Incontinence
- TURP syndrome
- DEFINITION: seizures or cardiovascular collapse caused by hypervolaemia and hyponatraemia due to absorption of glycine irrigation fluid
- Urinary infection
- Erectile dysfunction
- Urethral stricture
Summarise the prognosis for patients with benign prostatic hyperplasia
- Mild symptoms are usually well controlled medically
- Most patients get significant relief from surgery